| Plasma PCSK9 is associated with age, sex, and multiple metabolic markers in a population-based sample of children and adolescents A Baass, G Dubuc, M Tremblay, EE Delvin, J O'Loughlin, E Levy, ... Clinical chemistry 55 (9), 1637-1645, 2009 | 276 | 2009 |
| Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ... The Lancet 398 (10312), 1713-1725, 2021 | 198 | 2021 |
| Canadian Cardiovascular Society position statement on familial hypercholesterolemia: update 2018 LR Brunham, I Ruel, S Aljenedil, JB Rivière, A Baass, JV Tu, GBJ Mancini, ... Canadian Journal of Cardiology 34 (12), 1553-1563, 2018 | 134 | 2018 |
| Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia M Paquette, M Chong, S Thériault, R Dufour, G Paré, A Baass Journal of clinical lipidology 11 (3), 725-732. e5, 2017 | 119 | 2017 |
| Familial chylomicronemia syndrome: an under‐recognized cause of severe hypertriglyceridaemia A Baass, M Paquette, S Bernard, RA Hegele Journal of internal medicine 287 (4), 340-348, 2020 | 97 | 2020 |
| Chylomicronemia: differences between familial chylomicronemia syndrome and multifactorial chylomicronemia M Paquette, S Bernard, RA Hegele, A Baass Atherosclerosis 283, 137-142, 2019 | 92 | 2019 |
| The Montreal-FH-SCORE: a new score to predict cardiovascular events in familial hypercholesterolemia M Paquette, R Dufour, A Baass Journal of clinical lipidology 11 (1), 80-86, 2017 | 88 | 2017 |
| PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study YG Luna Saavedra, R Dufour, J Davignon, A Baass Arteriosclerosis, thrombosis, and vascular biology 34 (12), 2700-2705, 2014 | 86 | 2014 |
| Simplified Canadian definition for familial hypercholesterolemia I Ruel, D Brisson, S Aljenedil, Z Awan, A Baass, A Bélanger, J Bergeron, ... Canadian Journal of Cardiology 34 (9), 1210-1214, 2018 | 80 | 2018 |
| Regulation of poly (A) binding protein function in translation: Characterization of the Paip2 homolog, Paip2B JJ Berlanga, A Baass, N Sonenberg Rna 12 (8), 1556-1568, 2006 | 75 | 2006 |
| The effect of insulin on circulating PCSK9 in postmenopausal obese women Z Awan, G Dubuc, M Faraj, R Dufour, NG Seidah, J Davignon, ... Clinical biochemistry 47 (12), 1033-1039, 2014 | 64 | 2014 |
| Proprotein convertase subtilisin/kexin type 9 (PCSK9): lessons learned from patients with hypercholesterolemia Z Awan, A Baass, J Genest Clinical chemistry 60 (11), 1380-1389, 2014 | 60 | 2014 |
| Imputation of baseline LDL cholesterol concentration in patients with familial hypercholesterolemia on statins or ezetimibe I Ruel, S Aljenedil, I Sadri, E de Varennes, RA Hegele, P Couture, ... Clinical chemistry 64 (2), 355-362, 2018 | 56 | 2018 |
| Familial hypercholesterolemia: PCSK9 InsLEU genetic variant and prediabetes/diabetes risk YGL Saavedra, R Dufour, A Baass Journal of clinical lipidology 9 (6), 786-793. e1, 2015 | 56 | 2015 |
| Familial hypercholesterolemia-risk-score: a new score predicting cardiovascular events and cardiovascular mortality in familial hypercholesterolemia M Paquette, S Bernard, B Cariou, RA Hegele, J Genest, M Trinder, ... Arteriosclerosis, thrombosis, and vascular biology 41 (10), 2632-2640, 2021 | 54 | 2021 |
| Cardiovascular disease in familial hypercholesterolemia: validation and refinement of the Montreal-FH-SCORE M Paquette, D Brisson, R Dufour, É Khoury, D Gaudet, A Baass Journal of clinical lipidology 11 (5), 1161-1167. e3, 2017 | 54 | 2017 |
| Polygenic contribution to low-density lipoprotein cholesterol levels and cardiovascular risk in monogenic familial hypercholesterolemia M Trinder, M Paquette, L Cermakova, MR Ban, RA Hegele, A Baass, ... Circulation: Genomic and Precision Medicine 13 (5), 515-523, 2020 | 49 | 2020 |
| A simplified diagnosis algorithm for dysbetalipoproteinemia M Paquette, S Bernard, D Blank, G Paré, A Baass Journal of clinical lipidology 14 (4), 431-437, 2020 | 47 | 2020 |
| Regional distribution and metabolic effect of PCSK9 insLEU and R46L gene mutations and apoE genotype Z Awan, EE Delvin, E Levy, J Genest, J Davignon, NG Seidah, A Baass Canadian Journal of Cardiology 29 (8), 927-933, 2013 | 46 | 2013 |
| ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia M Paquette, R Dufour, A Baass Journal of Clinical Lipidology 12 (2), 383-389. e1, 2018 | 44 | 2018 |
